Aaron Guttmann
About Aaron Guttmann
Aaron Guttmann is the Director of Market Compliance and Compliance Committees, Intercon at Bristol Myers Squibb in Melbourne, Victoria, Australia, with over a decade of experience in compliance roles within the pharmaceutical industry.
Current Company
Aaron Guttmann currently serves as the Director of Market Compliance and Compliance Committees, Intercon at Bristol Myers Squibb in Melbourne, Victoria, Australia. He has been instrumental in identifying compliance trends and driving initiatives across the Intercon region.
Previous Roles
Before assuming his current role, Aaron Guttmann was the Compliance and Ethics Lead for Australia and New Zealand at Bristol Myers Squibb from 2013 to 2020, operating in the Melbourne Area, Australia. He also worked at Roche Products as Commercial Compliance Manager from 2011 to 2013. Prior to that, Guttmann held compliance roles at GlaxoSmithKline, including Corporate Compliance Manager for 7 months in 2010-2011, and Commercial Compliance Officer from 2008 to 2010.
Education and Expertise
Aaron Guttmann holds a Masters of Pharmacy, earned from Monash University from 1992 to 1994, following his Bachelor of Pharmacy (B.Pharm.) degree from the same institution, which he attained from 1988 to 1992. His academic background has provided a strong foundation for his extensive career in compliance roles within the pharmaceutical industry.
Years of Experience
Aaron Guttmann has over a decade of experience in compliance roles within the pharmaceutical sector, having held various positions at major companies such as Roche Products, GlaxoSmithKline, and Bristol Myers Squibb. His extensive experience in both commercial and corporate compliance management highlights his comprehensive understanding of the field.
Role at Bristol Myers Squibb
Aaron Guttmann has been with Bristol Myers Squibb for over a decade, where he has held several key roles in compliance and ethics. His long-standing tenure at the company reflects his commitment and expertise in addressing and navigating complex compliance issues within the pharmaceutical industry.